These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1471673)

  • 1. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults.
    Varela AF; Runge A; Ignarro LJ; Chaudhuri G
    Am J Obstet Gynecol; 1992 Dec; 167(6):1599-604. PubMed ID: 1471673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro.
    Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG
    Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical fate and biological action of peroxynitrite on human platelets.
    Moro MA; Darley-Usmar VM; Goodwin DA; Read NG; Zamora-Pino R; Feelisch M; Radomski MW; Moncada S
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6702-6. PubMed ID: 7517561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine 5'-diphosphate-induced platelet aggregation in uremia shows resistance to inhibition by the novel nitric oxide donor GEA 3175 but not by S-nitroso-N-acetylpenicillamine.
    Whiss PA; Larsson R
    Haemostasis; 1998; 28(5):260-7. PubMed ID: 10420076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets.
    Salas E; Moro MA; Askew S; Hodson HF; Butler AR; Radomski MW; Moncada S
    Br J Pharmacol; 1994 Aug; 112(4):1071-6. PubMed ID: 7524991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide stimulates the phosphorylation of rap1b in human platelets and acts synergistically with iloprost.
    Reep BR; Lapetina EG
    Biochem Biophys Res Commun; 1996 Feb; 219(1):1-5. PubMed ID: 8619788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term smoking impairs platelet-derived nitric oxide release.
    Ichiki K; Ikeda H; Haramaki N; Ueno T; Imaizumi T
    Circulation; 1996 Dec; 94(12):3109-14. PubMed ID: 8989117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels.
    Chaudhuri G; Cuevas J; Buga GM; Ignarro LJ
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2036-43. PubMed ID: 8285242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF).
    Barrett ML; Willis AL; Vane JR
    Agents Actions; 1989 Jun; 27(3-4):488-91. PubMed ID: 2508448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults.
    Lindkvist M; Fernberg U; Ljungberg LU; Fälker K; Fernström M; Hurtig-Wennlöf A; Grenegård M
    Thromb Res; 2019 Feb; 174():5-12. PubMed ID: 30543988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.